19767091

Source:http://linkedlifedata.com/resource/pubmed/id/19767091

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0280803, umls-concept:C1280477
pubmed:issue	9700
pubmed:dateCreated	2009-11-2
pubmed:commentsCorrections	http://linkedlifedata.com/resource/pubmed/commentcorrection/19767091-19767089
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/2985213R
pubmed:citationSubset	AIM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Antimetabolites, Antineoplastic, http://linkedlifedata.com/resource/pubmed/chemical/Cytarabine, http://linkedlifedata.com/resource/pubmed/chemical/Methotrexate
pubmed:status	MEDLINE
pubmed:month	Oct
pubmed:issn	1474-547X
pubmed:author	pubmed-author:O'BrienPeter CPC, pubmed-author:SeymourJohn FJF
pubmed:issnType	Electronic
pubmed:day	31
pubmed:volume	374
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	1477-8
pubmed:dateRevised	2010-1-11
pubmed:meshHeading	pubmed-meshheading:19767091-Antimetabolites, Antineoplastic, pubmed-meshheading:19767091-Antineoplastic Combined Chemotherapy Protocols, pubmed-meshheading:19767091-Central Nervous System Neoplasms, pubmed-meshheading:19767091-Clinical Trials, Phase II as Topic, pubmed-meshheading:19767091-Cytarabine, pubmed-meshheading:19767091-Humans, pubmed-meshheading:19767091-Lymphoma, pubmed-meshheading:19767091-Methotrexate, pubmed-meshheading:19767091-Randomized Controlled Trials as Topic
pubmed:year	2009
pubmed:articleTitle	Progress in primary CNS lymphoma.
pubmed:affiliation	Department of Radiation Oncology, Calvary Mater Newcastle, NSW 2310, Australia. peter.obrien@mater.health.nsw.gov.au
pubmed:publicationType	Journal Article, Comment